Pulmonary toxicity of chemotherapy

Seminars in Oncology

Volumn 33, Issue 1, 2006, Pages 98-105

  Meadors, Mark ^a   Floyd, Justin ^a   Perry, Michael C ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; BLEOMYCIN; BORTEZOMIB; BUSULFAN; CARMUSTINE; CETUXIMAB; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYTARABINE; DACTINOMYCIN; DOCETAXEL; ERLOTINIB; FLUDARABINE; GEFITINIB; GEMCITABINE; HYDROXYUREA; IFOSFAMIDE; IMATINIB; INTERLEUKIN 2; MELPHALAN; METHOTREXATE; MITOMYCIN; PACLITAXEL; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RETINOIC ACID; UNINDEXED DRUG; VINCA ALKALOID;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLERGIC PNEUMONITIS; ANAPHYLAXIS; ASCITES; BLEEDING; BRONCHITIS; BRONCHOSPASM; CAPILLARY LEAK SYNDROME; CARDIOGENIC SHOCK; COUGHING; CYANOSIS; DISEASE EXACERBATION; DRUG FATALITY; DRUG INDUCED DISEASE; DYSPLASIA; DYSPNEA; FEVER; FIBROSING ALVEOLITIS; FLUID RETENTION; GRANULOMA; HEART INFARCTION; HEART VENTRICLE FIBRILLATION; HEMATEMESIS; HEMOLYTIC UREMIC SYNDROME; HEMOPTYSIS; HUMAN; HYPERSENSITIVITY REACTION; HYPOTENSION; HYPOXEMIA; INTERSTITIAL PNEUMONIA; LEUKOCYTOSIS; LUNG ALVEOLUS CELL; LUNG EDEMA; LUNG EMBOLISM; LUNG FIBROSIS; LUNG INFILTRATE; LUNG INJURY; LUNG INSUFFICIENCY; LUNG TOXICITY; PERICARDIAL EFFUSION; PLEURA EFFUSION; PNEUMONIA; PRIORITY JOURNAL; RADIATION EXPOSURE; RESPIRATORY DISTRESS; RESPIRATORY FAILURE; REVIEW; TACHYPNEA; THROMBOTIC THROMBOCYTOPENIC PURPURA; TUMOR;

EID: 32244438528     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.11.005     Document Type: Article

References (64)

1. H. Kreisman, N. Wolkove Pulmonary toxicity of antineoplastic therapy Semin Oncol 19 1992 508 520
2. J.M. Hinson, A.W. Mckibben Chemotherapy-associated lung injury M.C. Perry Chemotherapy Source Book (ed 3) 2001 Williams & Wilkins Baltimore, MD 468 476
3. S.H. Abid, V. Malhotra, M.C. Perry Radiation-induced and chemotherapy-induced pulmonary injury Curr Opin Oncol 13 2001 242 248
4. S. Sleijfer Bleomycin-induced pneumonitis Chest 120 2001 617 624
5. B.I. Sikic Biochemical and cellular determinants of bleomycin cytotoxicity Cancer Surv 5 1986 81 91
6. D.A. Fennell, R.M. Rudd Pulmonary toxicity and cancer treatment Hosp Med 65 2004 462 464
7. D. Luedke, T. McLaughlin, C. Daughaday Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression Cancer 55 1985 542
8. M.P. Rivera, M.G. Kris, R.J. Gralla Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy Am J Clin Oncol 18 1995 245 250
9. A.Y. Chang, J.P. Kuebler, K.J. Pandya Pulmonary toxicity induced by mitomycin C is highly responsive to glucocorticoids Cancer 57 1986 2285 2290
10. R. Sheldon, D. Slaughter A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma Cancer 58 1986 1428 1436
11. E.C. Rosenow, R.J. Pisano Adverse effects of drugs on the lungs Contemp Intern Med 3 1991 25 34
12. P. Hilliquin, M. Renoux, S. Perrot Occurrence of pulmonary complications during methotrexate therapy in rheumatoid arthritis Br J Rheumatol 35 1996 441 445
13. E.W. St Clair, J.R. Rice, R. Snyder Pneumonitis complicating low-dose methotrexate therapy in rheumatoid arthritis Arch Intern Med 145 1985 2035
14. M.R. Golden, R.S. Katz, R.A. Balk The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis J Rheumatol 22 1995 1043 1047
15. A. Hassell, P. Dawes Serious problems with methotrexate Br J Rheumatol 33 1994 1001 1002
16. G.J. Carroll, R. Thomas, C.C. Phatouros Incidence, prevalence, and possible risk factors for pneumonitis with rheumatoid arthritis receiving methotrexate J Rheumatol 21 1994 51 54
17. E.C. Rosenow Drug induced pulmonary disease Dis Mon 40 1994 253 310
18. M. Patel, W. Ezzat, K.L. Pauw Bronchiolitis obliterans organizing pneumonia in a patient with chronic myelogenous leukemia developing after initiation of interferon and cytosine arabinoside Eur J Haematol 67 2001 318 321
19. E. Battistini, G. Dini, C. Savioli Bronchiolitis obliterans organizing pneumonia in three children with acute leukemias treated with cytosine arabinoside and anthracyclines Eur Respir J 10 1997 1187 1190
20. D.L. Helman, J.C. Byrd, N.C. Ales Fludarabine-related pulmonary toxicity A distinct clinical entity in chronic lymphoproliferative syndromes Chest 122 2002 785 790
21. D.F. Roychowdhury, C.A. Cassidy, P. Peterson A report on serious pulmonary toxicity associated with gemcitabine-based therapy Invest New Drugs 20 2002 311 315
22. C. Kouroussis, D. Mavroudis, S. Kakolyris High incidence of pulmonary toxicity of weekly docetaxel and gemcitabine in patients with non-small cell lung cancer Results of a dose-finding study Lung Cancer 44 2004 363 368
23. J.W. Frieberg, D. Neuberg, H. Kim Gemcitabine added to doxorubicin, bleomycin, and vinblastine for the treatment of de novo Hodgkin disease Unacceptable acute pulmonary toxicity Cancer 98 2003 978 982
24. H. Oliner, R. Schwartz, F. Rubio Interstitial pulmonary fibrosis following bulsulfan therapy Am J Med 31 1961 134 139
25. D.G. Hankins, S. Sanders, F.M. MacDonald Pulmonary toxicity recurring after a six week course of busulfan therapy and after subsequent therapy with uracil mustard Chest 73 1978 415 416
26. F. Rubio Possible pulmonary effects of alkylating agents N Engl J Med 287 1972 1150 1151
27. M. Mohr, D. Kingreen, H. Ruhl Interstitial lung disease - An underdiagnosed side effect of chlorambucil? Ann Hematol 67 1993 305 307
28. M.S. Akasheh, C.O. Freytes, D.H. Vesloe Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation Bone Marrow Transplant 26 2000 1107 1109
29. T. Cao, R. Negrin, K. Stockerl-Goldstein Pulmonary toxicity syndrome in breast cancer patients undergoing BCNU-containing high-dose chemotherapy and autologous hematopoietic cell transplantation Biol Blood Marrow Transplant 6 2000 387 394
30. L. Chap, R. Shpiner, M. Levine Pulmonary toxicity of high-dose chemotherapy for breast cancer A non-invasive approach to diagnosis and treatment Bone Marrow Transplant 20 1997 1063 1067
31. M. Kalaycioglu, M. Kavuru, L. Tuason Empiric prednisone therapy for pulmonary toxic reaction after high-dose chemotherapy containing carmustine (BCNU) Chest 107 1995 482 487
32. E.P. Alessandrino, P. Bernasconi, A. Colombo Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies Bone Marrow Transplant 25 2000 309 313
33. B.R. O'Driscoll, P.S. Hasleton, P.M. Taylor Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood N Engl J Med 323 1990 378 382
34. T. Mahmood, R. Mudad Pulmonary toxicity secondary to procarbazine Am J Clin Oncol 25 2002 187 188
35. E.K. Rowinsky, R.C. Donehower Paclitaxel (Taxol) N Engl J Med 332 1995 1004 1014
36. R.K. Ramanathan, V.V. Reddy, J.M. Holbert Pulmonary infiltrates following administration of paclitaxel Chest 110 1996 289 292
37. M. Merad, A.L. Cesne, P. Baldeyrou Docetaxel and interstitial pulmonary injury Ann Oncol 8 1997 191 194
38. M.L. Dunsford, G.M. Mead, A.C. Bateman Severe pulmonary toxicity in patients treated with a combination of docetaxel and gemcitabine for metastatic transitional cell carcinoma Ann Oncol 10 1999 943 947
39. P. Rouzaud, M. Estivals, M. Pujazon Respiratory complications of the vinorelbine-mitomycin combination Rev Mal Resp 16 1999 81 84
40. D.H. Johnson, L. Fehrenbacher, W. Novotny Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small cell lung cancer J Clin Oncol 22 2004 2184 2191
41. C. Burton, R. Kaczmarski, R. Mohamed Interstitial pneumonitis related to rituximab therapy N Engl J Med 26 2004 2690 2691
42. R. Swords, D. Power, M. Fay Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP) Am J Hem 77 2004 103 104
43. R.J. Leon, A. Gonsalvo, R. Salas Rituximab-induced acute pulmonary fibrosis Mayo Clin Proc 79 2004 949 953
44. ImClone Pharmaceutical Corporation Erbitux (cetuximab) prescribing information 2004 Brauchburg, NJ, February
45. Novartis Pharmaceuticals Corporation Gleevec (imatinib mesylate) prescribing information 2001 East Hanover, NJ, May
46. R. Goldsby, M. Pulsipher, R. Adams Unexpected pleural effusions in 3 pediatric patients treated with STI-571 J Pediatr Hematol Oncol 24 2002 694 695 (letter)
47. M.R. Rosado, E. Donna, Y.S. Ahn Imatinib mesylate-induce interstitial pneumonitis J Clin Oncol 21 2003 3171 3173
48. C.X. Ma, T.J. Hobday, J.R. Jett Imatinib mesylate-induced interstitial pneumonitis Mayo Clin Proc 78 2003 1578 1579
49. I. Isshiki, K. Yamaguchi, S. Okamoto Interstitial pneumonitis during imatinib therapy Br J Haematol 125 2004 420
50. A. Bergeron, E. Bergot, G. Vilela Hypersensitivity pneumonitis related to imatinib mesylate J Clin Oncol 20 2002 4270 4271
51. Astra Zeneca Pharmaceuticals Corporation Iressa (gefitnib) prescribing information 2005 Wilmington, DE, January
52. T.L. Evans Highlights from the tenth world conference on lung cancer Oncologist 9 2004 232 238
53. Genetech Pharmaceuticals Corporation Tarceva (erlotinib) prescribing information 2004 San Francisco, CA, November
54. R.J. Zitnik, R.A. Matthay Drug-induced lung disease M.I. Schwarz T.E. King Jr Interstitial Lung Disease 1998 Decker Hamilton, Canada 423 449
55. M.A. Gertz, M.Q. Lacy, J. Bjornsson Fatal pulmonary toxicity related to the administration of granulocyte colony-stimulating factor in amyloidosis A report and review of growth factor-induced pulmonary toxicity J Hematother Stem Cell Res 9 2000 635 643
56. J.H. Matthews Pulmonary toxicity of ABVD chemotherapy and G-CSF in Hodgkin's disease Possible synergy Lancet 342 1993 988 989
57. S.B. Saxman, C.R. Nichols, L.H. Einhorn Pulmonary toxicity in patients with advanced-stage germ cell tumors receiving bleomycin with and without granulocyte colony stimulating factor Chest 111 1997 657 660
58. C.F. Eisenbeis, D. Winn, S. Poelman A case of pulmonary toxicity associated with G-CSF and doxorubicin administration Ann Hematol 80 2001 121 123
59. N. Yokose, K. Ogata, H. Tamura Pulmonary toxicity after granulocyte colony-stimulating factor-combined chemotherapy for non-Hodgkin's lymphoma Br J Cancer 77 1998 2286 2290
60. E. Briasoulis, M. Froudarakis, H.J. Milionis Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor support Respiration 67 2000 680 683
61. A. Belch, C. Kouroukis, M. Crump Phase II trial of bortezomib in mantle cell lymphoma Blood 104 2004 175a (abstr 608)
62. H. Sandhu, P. Barnes, P. Hernandez Hydroxyurea-induced hypersensitivity pneumonitis A case report and literature review Can Respir J 7 2000 491 495
63. E. Chu V.T. DeVita Physicians' Cancer Chemotherapy Drug Manual 2004 2003 Jones & Bartlett Sudbury, MA
64. Y. Madarnas, P. Webster, A. Shorter Irinotecan-associated pulmonary toxicity Anti-Cancer Drugs 11 2000 709 713